Survey mortality risks according to ARO score in maintenance hemodialysis patients at Military Hospital 103
Main Article Content
Abstract
SUMMARY
A SURVEY ON THE MORTALITY RISKS ACCORDING TO ARO SCORE IN MAINTENANCE HEMODIALYSIS PATIENTS AT MILITARY HOSPITAL 103
Objective: To survey mortality risks according to ARO risk score and its relation with some clinical and preclinical criteria in maintenance hemodialysis patients at Military Hospital 103.
Patients and methods: A descriptive, cross-sectional study in 132 hemodialysis patients at Military Hospital 103 from October 2022 to March 2023. The all-cause mortality risks in 1 year and two years were assessed according to ARO risk score based on input variables including age, smoking status, etiology of chronic kidney disease, cardiovascular disease history, cancer history, body mass index, vascular access in the first 90 days of hemodialysis, actual blood flow, hemoglobin, serum ferritin, CRP level, serum creatinine, serum total calcium, serum albumin. The mortality risk score is calculated based on online software: https://aro-score.askimed.com/. Depending on the calculated risk score, the mortality risks were divided into three levels: low, moderate, and high.
Results: The mean one-year all-cause mortality risk was 13.4%, and the rates of patients at low, moderate and high mortality risks were 39.4%, 37.9% and 22.7%, respectively. The mean two-year all-cause mortality risk was 18.4%, the rates of patients at low, moderate and high mortality risks were 52.3%, 24.2% and 23.5%, respectively. Mortality risks were higher in patients with old age, decreased HDL-C level, general dyslipidemia, elevated serum CRP level but they were not associated with gender, hemodialysis time, serum cholesterol, triglyceride, LDL-C levels.
Conclusion: one-year and two-year all-cause mortality risks in maintenance hemodialysis patients were high. Increasing age, decreased HDL-C level, general dyslipidemia, and elevated serum CRP level could affect increasing mortality risks in maintenance hemodialysis patients.
Article Details
Keywords
ARO score, hemodialysis, mortality risks
References
2. Msaad R, Essadik R, Mohtadi K, et al. Predictors of mortality in hemodialysis patients. Pan Afr Med J. 2019; 33:61.
3. Floege J, Gillespie IA, Kronenberg F, et al. Development and validation of a predictive mortality risk score from a European hemodialysis cohort. Kidney Int. 2015; 87(5):996-1008.
4. De Francisco ALM, Kim J, Anker SD, et al. An epidemiological study of hemodialysis patients based on the European Fresenius Medical Care hemodialysis network: Results of the ARO study. Nephron Clin Pract. 2011; 118(2):c143-c154.
5. Garagarza C, Valente A, Caetano C, et al. Hypophosphatemia: Nutritional status, body composition, and mortality in hemodialysis patients. Int Urol Nephrol. 2017; 49(7):1243-1250.
6. Anker SD, Gillespie IA, Eckardt KU, et al. Development and validation of cardiovascular risk scores for haemodialysis patients. Int J Cardiol. 2016; 216:68-77.
7. Coric A, Resic H, Celik D, et al. Mortality in hemodialysis patients over 65 years of age. Mater Socio-Medica. 2015; 27(2):91-94.
8. Iseki K, Tozawa M, Yoshi S, et al. Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 1999; 14(8):1956-1960.
9. Navaneethan SD, Schold JD, Walther CP, et al. HDL-cholesterol and causes of death in chronic kidney disease. J Clin Lipidol. 2018; 12(4): 1061-1071.e7.
10. Noh HW, Jeon Y, Kim JH, et al. Higher serum total cholesterol to high-density lipoprotein cholesterol ratio is associated with increased mortality among incident peritoneal dialysis patients. Nutrients. 2021; 14(1):144.